Last reviewed · How we verify
Period 1 - Day 1: PF-04965842 administered
Period 1 - Day 1: PF-04965842 administered is a Small molecule drug developed by Pfizer. It is currently in Phase 1 development. Also known as: Single administration of PF-04965842 in Period 1..
At a glance
| Generic name | Period 1 - Day 1: PF-04965842 administered |
|---|---|
| Also known as | Single administration of PF-04965842 in Period 1. |
| Sponsor | Pfizer |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis (PHASE3)
- A Study to Determine the Effects of PF-04965842 on Midazolam PK in Healthy Volunteers (PHASE1)
- Drug Interaction Study Evaluating the Effect of Rifampin on PK and Safety of PF 04965842. (PHASE1)
- Study of PF 04965842 Effect on MATE1/2K Activity in Healthy Participants (PHASE1)
- A Study to Assess Pharmacokinetics of PF-04965842 and Its Metabolites and Effect of Probenecid in Healthy Participants (PHASE1)
- Drug Drug Interaction Study Evaluating the Effect of Fluvoxamine or Fluconazole on PK and Safety of PF-04965842. (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Period 1 - Day 1: PF-04965842 administered CI brief — competitive landscape report
- Period 1 - Day 1: PF-04965842 administered updates RSS · CI watch RSS
- Pfizer portfolio CI
Frequently asked questions about Period 1 - Day 1: PF-04965842 administered
What is Period 1 - Day 1: PF-04965842 administered?
Period 1 - Day 1: PF-04965842 administered is a Small molecule drug developed by Pfizer.
Who makes Period 1 - Day 1: PF-04965842 administered?
Period 1 - Day 1: PF-04965842 administered is developed by Pfizer (see full Pfizer pipeline at /company/pfizer).
Is Period 1 - Day 1: PF-04965842 administered also known as anything else?
Period 1 - Day 1: PF-04965842 administered is also known as Single administration of PF-04965842 in Period 1..
What development phase is Period 1 - Day 1: PF-04965842 administered in?
Period 1 - Day 1: PF-04965842 administered is in Phase 1.
Related
- Manufacturer: Pfizer — full pipeline
- Also known as: Single administration of PF-04965842 in Period 1.
- Compare: Period 1 - Day 1: PF-04965842 administered vs similar drugs
- Pricing: Period 1 - Day 1: PF-04965842 administered cost, discount & access